title: Market exclusivity after a prescription to nonprescription drug switch: striking the right balance between innovation and competition.
authors.affiliation: Consumer Healthcare Products Association (CHPA), Washington, D.C., USA
authors.forename: K J
authors.initials: KJ
authors.lastname: Kraushaar
mesh_terms: D017277:Drug Approval; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D011307:Drug Prescriptions; D016568:Drugs, Generic; D004465:Economic Competition; D006801:Humans; D008389:Marketing of Health Services; D004366:Nonprescription Drugs; D011356:Product Labeling / Q000331:legislation & jurisprudence; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D016568:Drugs, Generic; D004366:Nonprescription Drugs